Physician profile
Jennifer A Williams
NPI 1518732460
$6,552.70
in general payments reported to CMS, 2019-2025
54 companies · $3,948 in 2025
The $3,948 reported for 2025 was more than what 98% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $50.52 · 2024: $2,554 · 2025: $3,948.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,783 · Education: $595 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,783.07 |
| Education | $594.63 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $924.36 | 2024-2025 | Airsupra, Fasenra, Tezspire |
| E.R. Squibb & Sons, L.L.C. | $518.91 | 2024-2025 | Opdivo, Reblozyl |
| Regeneron Healthcare Solutions, INC. | $459.68 | 2024-2025 | Libtayo, Dupixent |
| Janssen Biotech, INC. | $391.96 | 2025 | Rybrevant, Carvykti, Erleada |
| Novartis Pharmaceuticals Corporation | $313.10 | 2024-2025 | |
| Amgen INC. | $300.14 | 2024 | Tezspire |
| Seagen INC. | $293.99 | 2025 | |
| Pfizer INC. | $287.71 | 2025 | |
| Merck Sharp & Dohme LLC | $262.75 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Puma Biotechnology, INC. | $225.04 | 2024-2025 | |
| Incyte Corporation | $200.49 | 2025 | Jakafi, Monjuvi, Zynyz |
| Glaxosmithkline, LLC. | $184.22 | 2024-2025 | Trelegy Ellipta, Ojjaara, Blenrep |
| Genzyme Corporation | $132.87 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $125.00 | 2025 | Xpovio |
| Sobi, INC | $124.00 | 2025 |
Show all 54 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $117.08 | 2024 | Opsumit, Uptravi |
| Inspire Medical Systems, INC. | $91.52 | 2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $90.01 | 2024 | Acthar |
| Daiichi Sankyo INC. | $83.67 | 2024-2025 | Enhertu, Datroway |
| 3b Medical, INC. | $80.06 | 2024 | Luna |
| Bayer Healthcare Pharmaceuticals INC. | $74.69 | 2024-2025 | |
| Legend Biotech USA INC. | $72.88 | 2025 | Carvykti |
| Philips North America LLC | $71.19 | 2024-2025 | (Ae4) Secretion Management, Vest Therapy Und, Image Management Subscription |
| Geron Corporation | $62.41 | 2025 | Rytelo |
| Takeda Pharmaceuticals U.S.A., INC. | $60.02 | 2024 | Glassia |
| Kyowa Kirin, INC. | $59.42 | 2025 | |
| Array Biopharma INC | $59.40 | 2025 | Braftovi, Mektovi, Tukysa |
| Abbvie INC. | $57.16 | 2025 | |
| Vifor Pharma, INC. | $56.01 | 2024 | Zemaira |
| Gilead Sciences, INC. | $53.75 | 2025 | Trodelvy |
| Mylan Specialty L.P. | $50.41 | 2024 | Yupelri |
| Pharmaessentia USA Corporation | $43.49 | 2025 | Besremi |
| Alexion Pharmaceuticals, INC. | $43.03 | 2025 | Ultomiris |
| Phadia US INC. | $42.22 | 2023-2024 | Immunocap |
| Novocure INC. | $42.06 | 2024-2025 | Optune Gio, Optune Lua (Novottf-200t) |
| Emd Serono, INC. | $40.70 | 2025 | |
| United Therapeutics Corporation | $39.02 | 2024 | Tyvaso |
| Insmed, INC. | $38.10 | 2024 | Arikayce |
| Blueprint Medicines Corporation | $37.04 | 2025 | Ayvakit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $31.40 | 2024 | Ofev |
| Recordati_rare_diseases_inc. | $30.87 | 2025 | Enjaymo |
| Immunocore Limited | $27.26 | 2025 | Kimmtrak |
| Beone Medicines USA, INC. | $25.52 | 2025 | Tevimbra |
| Genentech USA, INC. | $25.11 | 2025 | Polivy |
| Lilly USA, LLC | $24.37 | 2025 | Jaypirca, Verzenio |
| Servier Pharmaceuticals LLC | $23.35 | 2025 | |
| Verona Pharma, INC. | $22.04 | 2025 | Ohtuvayre |
| Agios Pharmaceuticals, INC. | $21.64 | 2025 | Pyrukynd |
| Eisai INC. | $20.85 | 2024 | |
| Sun Pharmaceutical Industries INC. | $19.85 | 2025 | |
| Jazz Pharmaceuticals INC. | $18.95 | 2025 | |
| Pharmacosmos Therapeutics INC. | $18.66 | 2025 | Monoferric |
| Electromed, INC. | $18.23 | 2024 | Smartvest |
| Azurity Pharmaceuticals, INC. | $15.04 | 2025 | Danziten |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.